ASX Announcements
Notification regarding unquoted securities - ASX
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities)
- Nov 4, 2024
- 6 pages
Notification regarding unquoted securities - ASX
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities)
- Nov 4, 2024
- 6 pages
This Month
ASX denies breaking law over CHESS status, relied on technology vendor
Exchange boss Helen Lofthouse said it is in the interests of the company and its shareholders for it to defend a case alleging misstatements about the project.
- Updated
- James Eyers
Getting off the grog isn’t easy. Ask Woolworths
The supermarket group cleaned up its image after divesting from booze and pokie assets.
- Mark Di Stefano
Qantas plans lavish farewell for Richard Goyder
He led the company to an excruciating reputational crisis. But he will exit to well-wishes and speeches delivered in one of Sydney’s most salubrious hotels
- Myriam Robin
Trump trade sweeps across global markets on Republican victory
Bitcoin and US equities have surged and bonds have fallen as global investors scrambled to shore up their investments under a Donald Trump presidency.
- Updated
- Joshua Peach
The complicity of Chris Ellison’s financiers
Those around the MinRes managing director are forever effusive in their praise.
- Mark Di Stefano
NZ firm turns $1b unicorn helping kids get into elite unis
The 11-year-old Crimson Education has cracked the billion-dollar valuation after a small fundraising round led by New Zealand venture capitalists.
- Paul Smith
Crowdfunding platform Equitise calls in administrators
Equitise, which helps companies raise capital without hiring expensive investment bankers, fails to secure fresh funding needed to keep its operations afloat.
- Paul Smith
Ellison’s executives revealed as owners in blockbuster lithium IPO
Mark Wilson was among a group of executives who report to Chris Ellison, who bought into Kali Metals – the miner targeted by Mineral Resources.
- Mark Di Stefano and Neil Chenoweth
October
ASX risks falling behind on CHESS remake
The new system underpinning clearing and settlement was set for testing in February 2025, but ASIC monitoring casts doubt on that target.
- Lucas Baird
The strategy that can turn $10,000 to $102,000 in two decades
An investing strategy popularised by Peter Lynch is finding favour again.
- Lucy Dean
These stock pickers are beating the investment behemoths
Boutique funds have come out on top for returns in the third quarter, posting gains up to 40 per cent as rate relief and China stimulus sent stocks soaring.
- Joshua Peach
ASX hit with ‘first strike’ at AGM over regulatory concerns
David Clarke and Wayne Byres were elected to the ASX board with strong support, but it faced a backlash on executive bonuses as the CHESS fallout continues.
- James Eyers
2024’s most powerful and influential directors revealed
As AGM season gathers pace, the BOSS index of the country’s most powerful and influential directors reveals a new cohort rising through the ranks.
- Patrick Durkin
- Opinion
- Governance
Chris Ellison and Richard White should stand aside
MinRes and WiseTech have done the minimum necessary to buy time. The companies are offering crisis management, not good governance.
- Updated
- Helen Bird
Pharmacy lobby says Chemist Warehouse concessions are ‘tokenistic’
The influential industry group is urging the competition regulator to reject an $8.8 billion merger with Sigma Healthcare. A decision is due early next month.
- Carrie LaFrenz
- Opinion
- The AFR View
A rare insight into the role of founders in listed companies
There can be a tension between the maverick individualist approach needed to create new businesses from scratch, and the obligations of a public company.
- The AFR View
Want to trade options? The ASX can teach you how
Ainsley Marcus, 34, says playing the ASX options game showed her investing could be more interesting than “just buying and selling shares”. But her money is still with ETFs.
- Michelle Bowes
Lady Gaga portends ASX pay blushes
Clinuvel Pharmaceuticals CEO Philippe Wolgen sidles up to celebrities before shareholders ding his generous pay.
- Mark Di Stefano
Super Retail accused of intimidation, victimisation by former exec
Court documents claim whistleblower Amelia Berczelly was “scared and sickened” as she grappled with an ASX statement she worried may have identified her.
- Carrie LaFrenz
FinClear nabs licence that could threaten ASX’s monopoly
Regulators have cleared the way for the Magellan Financial-backed company to allow shares in private companies to be traded with blockchain technology.
- Updated
- James Eyers